Clinical Commissioning Policy: Sodium oxybate for symptom control of narcolepsy with cataplexy (children and adolescents aged 7 until 19 years)

Document first published:
Page updated:
Topic:
Publication type:

This clinical commissioning policy outlines the criteria when we will commission sodium oxybate for symptom control of narcolepsy with
cataplexy (children and adolescents, aged 7 until they are 19 years old).

Document

Sodium oxybate for symptom control of narcolepsy with cataplexy (children and adolescents aged 7 until 19 years)

Sodium oxybate for symptom control of narcolepsy with cataplexy (children and adolescents aged 7 until 19 years)

  • PDF
  • 125 KB
  • 18 pages